ID   CLB-Bar
AC   CVCL_9519
SY   CLB-BAR
DR   ArrayExpress; E-MTAB-6654
DR   PRIDE; PXD011187
DR   Wikidata; Q54813540
RX   PubMed=20160348;
RX   PubMed=30459281;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Unexplicit; Ex4-11; Zygosity=Unspecified (PubMed=30459281).
CC   Omics: Deep phosphoproteome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Miscellaneous: Sex of donor from personal communication of Combaret, Valerie.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GP62 ! CLB-BARrec
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
RX   PubMed=20160348; DOI=10.1172/JCI41013; PMCID=PMC2827960;
RA   Bouzas-Rodriguez J., Cabrera J.R., Delloye-Bourgeois C., Ichim G.,
RA   Delcros J.-G., Raquin M.-A., Rousseau R., Combaret V., Benard J.,
RA   Tauszig-Delamasure S., Mehlen P.;
RT   "Neurotrophin-3 production promotes human neuroblastoma cell survival
RT   by inhibiting TrkC-induced apoptosis.";
RL   J. Clin. Invest. 120:850-858(2010).
//
RX   PubMed=30459281; DOI=10.1126/scisignal.aar5680;
RA   Van den Eynden J., Umapathy G., Ashouri A., Cervantes-Madrid D.,
RA   Szydzik J., Ruuth K., Koster J., Larsson E., Guan J.-K., Palmer R.H.,
RA   Hallberg B.;
RT   "Phosphoproteome and gene expression profiling of ALK inhibition in
RT   neuroblastoma cell lines reveals conserved oncogenic pathways.";
RL   Sci. Signal. 11:eaar5680.1-eaar5680.16(2018).
//